UK markets close in 16 minutes
  • FTSE 100

    7,510.12
    -25.94 (-0.34%)
     
  • FTSE 250

    20,037.95
    -298.46 (-1.47%)
     
  • AIM

    924.88
    -6.66 (-0.71%)
     
  • GBP/EUR

    1.1848
    -0.0041 (-0.34%)
     
  • GBP/USD

    1.2042
    -0.0052 (-0.43%)
     
  • BTC-GBP

    19,428.20
    -385.91 (-1.95%)
     
  • CMC Crypto 200

    554.92
    -17.90 (-3.12%)
     
  • S&P 500

    4,263.23
    -41.97 (-0.97%)
     
  • DOW

    33,918.44
    -233.57 (-0.68%)
     
  • CRUDE OIL

    87.56
    +1.03 (+1.19%)
     
  • GOLD FUTURES

    1,779.40
    -10.30 (-0.58%)
     
  • NIKKEI 225

    29,222.77
    +353.86 (+1.23%)
     
  • HANG SENG

    19,922.45
    +91.93 (+0.46%)
     
  • DAX

    13,634.11
    -276.01 (-1.98%)
     
  • CAC 40

    6,521.34
    -71.24 (-1.08%)
     

Eckert & Ziegler: Strong Growth in Revenues and Earnings in 2nd Quarter

  • Oops!
    Something went wrong.
    Please try again later.
·2-min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word(s): Half Year Results
Eckert & Ziegler: Strong Growth in Revenues and Earnings in 2nd Quarter

27-Jul-2022 / 12:53 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

Insider information pursuant to Article 17 MA

 

Eckert & Ziegler: Strong Growth in Revenues and Earnings in 2nd Quarter

Berlin, 27 July 2022. Based on initial, unaudited assessments, revenues of Berlin-based isotope specialists Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700) for the second quarter increased by 26% from 45,3 to 56,9 mm EUR. Compared to last year’s second quarter, the net income only increased by around 5% from 8,5 to 8,9 mm EUR. However, the direct comparison is misleading, as untypically low taxes were recognized in the previous year due to special effects. Using Earnings before Taxes as a comparator, profits in the second quarter of 2022 rose by around 60% from 8,7 to 13,9 mm EUR.

Prime reason for the profit increase, apart from favourable exchange rates, were stronger sales in the Isotope segment of industrial products and radiopharmaceuticals.

The complete figures for the second quarter 2022 will be published on 11 August 2022.

 

For enquiries please contact:

Eckert & Ziegler AG, Karolin Riehle, Investor Relations

Robert-Rössle-Str. 10, 13125 Berlin, Germany

Tel.: +49 (0) 30 / 94 10 84-138, karolin.riehle@ezag.de, www.ezag.com

27-Jul-2022 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de

Language:

English

Company:

Eckert & Ziegler Strahlen- und Medizintechnik AG

Robert-Rössle-Str.10

13125 Berlin

Germany

Phone:

+49 30 941084-138

Fax:

+49 30 941084-112

E-mail:

karolin.riehle@ezag.de

Internet:

www.ezag.de

ISIN:

DE0005659700

WKN:

565970

Indices:

SDAX

Listed:

Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange

EQS News ID:

1407141


 

End of Announcement

DGAP News Service

show this
show this
Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting